Engineering biology into productive systems.

Cyvora Biotech develops biological production technologies that convert under-used resources into biomass, biological compounds and useful products. Our platform brings together algae cultivation, biological conversion, carbon utilisation and downstream processing, connecting environmental resource recovery with agriculture, aquaculture, energy and materials.

The central principle is simple: biology should not only be protected; it can also be engineered, cultivated and integrated into productive systems.

The platform works with several kinds of input — carbon dioxide, organic residues, water, nutrients and sunlight. These are processed through biological systems such as microalgae and microbial processes, generating biomass and other biological outputs that can then be harvested, concentrated, stabilised, formulated or refined further.

Algae is the flagship component, because it provides a biological route for converting light, CO₂ and nutrients into biomass quickly. Depending on the organism and the cultivation conditions, that biomass can contain proteins, lipids, carbohydrates, pigments, minerals and other compounds with commercial applications.

So the platform extends beyond producing algae itself. We are developing the capability to move from cultivation to carbon utilisation, biomass recovery, biorefining and product development — one biological production infrastructure supporting several product streams rather than being tied to one output.

This matters because the world faces climate and resource pressures at the same time. Energy-related CO₂ emissions reached 37.8 gigatonnes in 2024, according to the International Energy Agency's Global Energy Review 2025, while demand for food, animal nutrition and agricultural inputs continues to rise.

Our technology strategy is therefore built around a productive form of resource management: capture biological value, convert it efficiently, recover the useful fractions and return them to the economy.

Our technologies are developed through defined stages, from research and development to validation, piloting, scale-up and commercialisation. We distinguish those stages publicly so that customers, research partners and investors can see what has been demonstrated and what is still being developed.